Cite
HARVARD Citation
Que, Z. et al. (2021). Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72–88]. Pharmacological research. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Que, Z. et al. (2021). Corrigendum to "Dihydroartemisin inhibits glioma invasiveness via a ROS to P53 to β-catenin signaling" [Pharmacol. Res. 119 (2017) 72–88]. Pharmacological research. p. . [Online].